Table 1.
The characteristics of the subjects with NAFLD and controls.
Table 2.
Correlations between GH and features of the metabolic syndrome.
Table 3.
Stepwise logistic regression analysis using NAFLD as dependent variable.
Figure 1.
The prevalence of NAFLD and the metabolic syndrome in the subjects with different serum GH levels.
The group with higher GH levels showed a lower prevalence of NAFLD, the metabolic syndrome, central obesity, elevated blood pressure, hypertriglyceridemia, and low HDL-C level than the group with lower GH levels. Abbreviations: BP: blood pressure; FBG: fasting blood glucose; GH: growth hormone; HDL-c: high-density lipoprotein cholesterol; MS: metabolic syndrome; NAFLD: nonalcoholic fatty liver disease; TG: triglyceride.